105 related articles for article (PubMed ID: 11817260)
1. Determination of NTx in second-morning urine: a proposal for the standardization of morning urine collection.
Wendlová J; Mikulecký M
Wien Med Wochenschr; 2001; 151(18-20):472-5. PubMed ID: 11817260
[TBL] [Abstract][Full Text] [Related]
2. [Suggestions for standardized collection of morning urine for assessment of NTx levels in patients with osteoporosis].
Wendlová J
Vnitr Lek; 2001 Jan; 47(1):30-5. PubMed ID: 15635866
[TBL] [Abstract][Full Text] [Related]
3. [Normal urine levels of the aminoterminal telopeptide of type I collagen (NTx) in premature newborns in the first week of life].
Praticò G; Palano GM; Curreri R; Marletta M; Parisi G; Praticò ER
Pediatr Med Chir; 2005; 27(1-2):81-5. PubMed ID: 16922049
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of bone turnover markers in healthy premenopausal women.
de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
[TBL] [Abstract][Full Text] [Related]
5. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
[TBL] [Abstract][Full Text] [Related]
6. [Linear regression analysis of values of the calciuria index, N-telopetide and bone mineral density in patients with osteoporosis].
Wendlová J; Mikulecký M; Rácová K
Vnitr Lek; 1999 Mar; 45(3):159-62. PubMed ID: 15641239
[TBL] [Abstract][Full Text] [Related]
7. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
D'Amore M; Fanelli M; D'Amore S; Fontana A; Minenna G
Panminerva Med; 2006 Dec; 48(4):215-21. PubMed ID: 17215793
[TBL] [Abstract][Full Text] [Related]
8. Variability of collagen crosslinks: impact of sample collection period.
Smith SM; Dillon EL; DeKerlegand DE; Davis-Street JE
Calcif Tissue Int; 2004 Apr; 74(4):336-41. PubMed ID: 15255070
[TBL] [Abstract][Full Text] [Related]
9. Intraindividual variability in bone markers in the urine.
Jensen JE; Kollerup G; Sørensen HA; Sørensen OH
Scand J Clin Lab Invest Suppl; 1997; 227():29-34. PubMed ID: 9127466
[TBL] [Abstract][Full Text] [Related]
10. Urinary N-telopeptides of type I collagen in healthy children.
Sato J; Hasegawa K; Tanaka H; Morishima T
Pediatr Int; 2010 Jun; 52(3):398-401. PubMed ID: 20113422
[TBL] [Abstract][Full Text] [Related]
11. [Comparative quantitative clinico-chemical analysis of the characteristics of 24-hour urine and morning urine].
Krieg M; Gunsser KJ; Steinhagen-Thiessen E; Becker H
J Clin Chem Clin Biochem; 1986 Nov; 24(11):863-9. PubMed ID: 3806015
[TBL] [Abstract][Full Text] [Related]
12. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
[TBL] [Abstract][Full Text] [Related]
14. [Normal urinary levels of telopeptide aminoterminal (NTx) of type I collagen in healthy term newborns and infants in the first month of life].
Praticò G; Palano GM; Curreri R; D'Agata A; Carpinato C; Sottile F; Sorge A
Pediatr Med Chir; 2002; 24(3):213-6. PubMed ID: 12236035
[TBL] [Abstract][Full Text] [Related]
15. Establishing a reference range for bone turnover markers in young, healthy women.
Glover SJ; Garnero P; Naylor K; Rogers A; Eastell R
Bone; 2008 Apr; 42(4):623-30. PubMed ID: 18289953
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
[TBL] [Abstract][Full Text] [Related]
17. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load.
Generali D; Berruti A; Tampellini M; Dovio A; Tedoldi S; Bonardi S; Tucci M; Allevi G; Aguggini S; Milani M; Bottini A; Dogliotti L; Angeli A
Bone; 2007 Jan; 40(1):182-8. PubMed ID: 16935041
[TBL] [Abstract][Full Text] [Related]
18. Can overnight urine replace 24-hour urine collection to measure urinary calcium in epidemiologic studies?
Cirillo M; Mellone M; De Santo NG
Miner Electrolyte Metab; 1993; 19(6):385-8. PubMed ID: 8164621
[TBL] [Abstract][Full Text] [Related]
19. Screening for microalbuminuria in type 2 diabetes: a reconsideration.
Soonthornpun S; Leelawattana R; Thamprasit A; Rattarasarn C; Setasuban W; Thammakumpee N
J Med Assoc Thai; 2002 May; 85(5):604-11. PubMed ID: 12188392
[TBL] [Abstract][Full Text] [Related]
20. Assessment of urinary N-telopeptide: point-of-care testing, sample types, and relationship to urinary helical peptide excretion.
Zwart SR; DeKerlegand DE; Davis-Street JE; Smith SM
Clin Chim Acta; 2006 Oct; 372(1-2):65-9. PubMed ID: 16678144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
